Zebra Analytix Announces Upcoming Launch of ScentZ GC
Zebra Analytix, a leader in advanced chemical analysis technologies, today announced the upcoming launch of its ScentZ GC compact Gas Chromatograph.
Zebra Analytix, a leader in advanced chemical analysis technologies, today announced the upcoming launch of its ScentZ GC compact Gas Chromatograph.
The VIC Fellows Program offers experienced professionals the opportunity to learn how to identify and evaluate high-potential innovations from around the world. We’re proud to showcase the members of the 2025–2026...
VIC Tech is pleased to announce the appointment of Rajeev Nair, a seasoned global business executive with nearly three decades of experience scaling and transforming multinational organizations, to its Strategic...
Introduction VIC Technology Venture Development is pleased to introduce the second installment in a new educational series on international market access for IVD tests. This White Paper developed by our strategic...
In the third part of the continuing series on the broader topic of Fostering Life Science Innovation, we zoom in on the important concept of transitioning technologies from the university lab to the next stage of...
Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions announced today a key leadership transition. Dr. Matthew Leming, PhD, formerly Chief Scientific Officer, has been appointed...
DALLAS, Oct. 21, 2025 -- Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its...
The VIC Fellows Program offers experienced professionals the opportunity to learn how to identify and evaluate high-potential innovations from around the world. We’re proud to showcase the members of the 2025–2026...
Investing in life sciences is both challenging and rewarding. The sector demands significant capital, long timelines, and careful diligence, but it also offers the chance to back breakthroughs that improve and save...
VIC Tech is pleased to announce the appointment of Alex Cameron to its Strategic Advisory Board (SAB). Alex is a globally experienced life sciences executive with a proven track record of launching innovative products,...
Zebra Analytix, a leader in advanced chemical analysis technologies, today announced the successful completion of its contract with the Intelligence Advanced Research Projects Activity (IARPA) for the PICARD project.
Cellia Science a biotechnology company advancing rapid, cell-based diagnostic technologies, announced today that it has been awarded a $306,872 Small Business Innovation Research (SBIR) Phase I grant from the National...
Enhance Diagnostics, announced today that it has been awarded a $307,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Child Health and Human Development (NICHD), part of the...
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Dr. Jeff White to its Strategic Advisory Board (SAB). A seasoned life science...
The life sciences industry has always been shaped by waves of disruption, but in 2025 the turbulence feels more structural than cyclical. Early-stage companies and their investors now find themselves facing delayed...
Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the appointment of Taru Dutt, PhD, as Director of Bacterial Countermeasures. This strategic addition strengthens...
In 2024, the University of Lausanne licensed its technology into i-Seq Biotechnology, Inc., a company formed by VIC Tech to advance novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens...
Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the addition of an accomplished scientist to its leadership team. Jonathan O. Rayner, PhD, joins as Chief...
The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...
VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Virender “VK” Sharma, MD, to its Strategic Advisory Board (SAB). A recognized...
Introduction VIC Technology Venture Development is pleased to introduce the first installment in a new educational series on international market access for life science innovations. This white paper, developed by our...
In an industry where advanced degrees and technical titles often take center stage, Laura Lyons brings something just as powerful to the table; lived experience, heart, and a relentless drive to make life better for...
Fayetteville, AR – July 8, 2025 – Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announcethe addition of two prominent experts to its Strategic Advisory Board: Dr. Mark Parry-Billings, a seasoned biotech and pharmaceutical executive with...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
Cellia Science announced today it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National...
Launched in 2019, the VIC Fellows Program was created to harness the talents of individuals from a wide variety of scientific, medical, and commercial backgrounds and immerse them in the dynamic world of life science...
The first article in this series [blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap] set the stage by defining the primary components, drivers and benefits of life science innovation...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
Tell us about Enhance Diagnostics. Enhance Diagnostics is a trailblazing medical diagnostics company developing breath-based, at-home testing for chronic conditions such as a Urea Cycle Disorder (UCD) and Chronic Kidney...
April 2, 2025- ADDISON, TX – Solenic Medical Inc., a pioneering medical device company focused on non-invasive solutions for infected metallic implants, today announced a significant achievement in its mission. The...
Fayetteville, AR / Bethel, CT – SFC Fluidics, Inc. (“SFC”) and Duracell U.S. Operations, Inc. (“Duracell”) are collaborating to efficiently deliver power to SFC’s dual-hormone insulin and glucagon delivery pod. The goal...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
Introduction What does it take to create and nurture life science innovation and why is it important? No doubt, this is a broad and deep topic, and would not be adequately addressed in a single white paper. As a result,...
FAYETTEVILLE, AR – VIC Tech is pleased to announce the appointment of Silji Abraham to its Board of Directors. Abraham brings over 25 years of leadership experience across healthcare, life sciences, medical devices,...
DALLAS, TX – Solenic Medical Inc., a pioneering company in non-invasive infection control for metallic implants, proudly announces the addition of three distinguished experts to its advisory boards. The expansion...
2024 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.
Expanding Operations in Atlanta to Foster Life Science Innovation Across the Southeast. ATLANTA, GA – January 20, 2025 – VIC announced today that Tony Cruz has joined the firm as Managing Director of its Atlanta branch....
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
FEATURED RESOURCES
Technology Solutions For A Better World
Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.
Subscribe to the VIC newsletter.